SUMMARY: BACKGROUND AND METHODS: As a source of hematopoietic stem cells, cord blood (CB) is an alternative to bone marrow or peripheral blood stem cells (PBSC). The Mannheim Cord Blood Bank has currently stored about 1,750 allogeneic CB units. Here we report our experiences and discuss future perspectives of CB banking. We analyzed CB units for nucleated cell (NC), mononucleated cell (MNC) and CD34+ cell count, volume, colony-forming units (CFU-GM) as well as ethnic background of the donor. Transplanted CB units were analyzed for patient and transplant characteristics and compared to stored CB units. RESULTS: Only 25% of all collected CB units met storage criteria. Main reasons for exclusion were: i) insufficient volume (57.7%), ii) delayed arrival at the processing site (19.2%) and iii) little cell count (7.2%). Up to now 36 CB units have been released for transplantation mainly to children (62%). Transplant indications were hematological diseases, immune deficiencies and metabolic diseases. Transplanted CB units showed significantly higher cell counts compared to stored units (NC: 12.5 vs. 7.2 x 10(8), MNC: 4.7 vs. 2.9 x 10(8), CD34+ cells: 3.3 vs. 1.8 x 10(6), mean; p < 0.001 each) and were found more often in ethnic minority groups (36 vs. 20%; p = 0.04). CONCLUSIONS: Even though cell count and volume are key parameters for the eligibility of CB units, our data indicate that the ethnic background of the donor also plays a major role. Collection and processing of CB should be optimized in order to gain maximum volume and cell counts.
SUMMARY: BACKGROUND AND METHODS: As a source of hematopoietic stem cells, cord blood (CB) is an alternative to bone marrow or peripheral blood stem cells (PBSC). The Mannheim Cord Blood Bank has currently stored about 1,750 allogeneic CB units. Here we report our experiences and discuss future perspectives of CB banking. We analyzed CB units for nucleated cell (NC), mononucleated cell (MNC) and CD34+ cell count, volume, colony-forming units (CFU-GM) as well as ethnic background of the donor. Transplanted CB units were analyzed for patient and transplant characteristics and compared to stored CB units. RESULTS: Only 25% of all collected CB units met storage criteria. Main reasons for exclusion were: i) insufficient volume (57.7%), ii) delayed arrival at the processing site (19.2%) and iii) little cell count (7.2%). Up to now 36 CB units have been released for transplantation mainly to children (62%). Transplant indications were hematological diseases, immune deficiencies and metabolic diseases. Transplanted CB units showed significantly higher cell counts compared to stored units (NC: 12.5 vs. 7.2 x 10(8), MNC: 4.7 vs. 2.9 x 10(8), CD34+ cells: 3.3 vs. 1.8 x 10(6), mean; p < 0.001 each) and were found more often in ethnic minority groups (36 vs. 20%; p = 0.04). CONCLUSIONS: Even though cell count and volume are key parameters for the eligibility of CB units, our data indicate that the ethnic background of the donor also plays a major role. Collection and processing of CB should be optimized in order to gain maximum volume and cell counts.
Authors: P Ljungman; M Bregni; M Brune; J Cornelissen; T de Witte; G Dini; H Einsele; H B Gaspar; A Gratwohl; J Passweg; C Peters; V Rocha; R Saccardi; H Schouten; A Sureda; A Tichelli; A Velardi; D Niederwieser Journal: Bone Marrow Transplant Date: 2009-07-06 Impact factor: 5.483
Authors: J A Ademokun; C Chapman; J Dunn; D Lander; K Mair; S J Proctor; A M Dickinson Journal: Bone Marrow Transplant Date: 1997-05 Impact factor: 5.483
Authors: Vanderson Rocha; Myriam Labopin; Guillermo Sanz; William Arcese; Rainer Schwerdtfeger; Alberto Bosi; Niels Jacobsen; Tapani Ruutu; Marcos de Lima; Jürgen Finke; Francesco Frassoni; Eliane Gluckman Journal: N Engl J Med Date: 2004-11-25 Impact factor: 91.245
Authors: V Rocha; J E Wagner; K A Sobocinski; J P Klein; M J Zhang; M M Horowitz; E Gluckman Journal: N Engl J Med Date: 2000-06-22 Impact factor: 91.245
Authors: Sergio Querol; Ghulam J Mufti; Steven G E Marsh; Antonio Pagliuca; Ann-Margaret Little; Bronwen E Shaw; Robert Jeffery; Joan Garcia; John M Goldman; J Alejandro Madrigal Journal: Haematologica Date: 2009-02-19 Impact factor: 9.941
Authors: Mary Eapen; Pablo Rubinstein; Mei-Jie Zhang; Cladd Stevens; Joanne Kurtzberg; Andromachi Scaradavou; Fausto R Loberiza; Richard E Champlin; John P Klein; Mary M Horowitz; John E Wagner Journal: Lancet Date: 2007-06-09 Impact factor: 79.321
Authors: Thomas Bart; Michael Boo; Snejana Balabanova; Yvonne Fischer; Grazia Nicoloso; Lydia Foeken; Machteld Oudshoorn; Jakob Passweg; Andre Tichelli; Vincent Kindler; Joanne Kurtzberg; Thomas Price; Donna Regan; Elizabeth J Shpall; Rudolf Schwabe Journal: Transfus Med Hemother Date: 2013-01-07 Impact factor: 3.747
Authors: Howard R Seay; Amy L Putnam; Judit Cserny; Amanda L Posgai; Emma H Rosenau; John R Wingard; Kate F Girard; Morey Kraus; Angela P Lares; Heather L Brown; Katherine S Brown; Kristi T Balavage; Leeana D Peters; Ashley N Bushdorf; Mark A Atkinson; Jeffrey A Bluestone; Michael J Haller; Todd M Brusko Journal: Mol Ther Methods Clin Dev Date: 2016-12-24 Impact factor: 6.698
Authors: Rianne Opstelten; Manon C Slot; Neubury M Lardy; Arjan C Lankester; Arend Mulder; Frans H J Claas; Jon J van Rood; Derk Amsen Journal: Sci Rep Date: 2019-03-27 Impact factor: 4.379
Authors: Jeremy Magalon; Martin Maiers; Joanne Kurtzberg; Cristina Navarrete; Pablo Rubinstein; Colin Brown; Catherine Schramm; Jérome Larghero; Sandrine Katsahian; Christian Chabannon; Christophe Picard; Alexander Platz; Alexander Schmidt; Gregory Katz Journal: PLoS One Date: 2015-12-01 Impact factor: 3.240